The reported statements, read against the company's own industry.
Financials view
Market Capitalization
169.26MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue (TTM)
124.51MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
-20.22%
Updated Oct 27, 2026
Beta
2.45x
vs all stocks
Updated Oct 27, 2026
52-Week Change
-8.39%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
169.26MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
156.57MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Price to Sales (TTM)
1.36x
Updated Oct 27, 2026
Price to Book (MRQ)
2.41x
Updated Oct 27, 2026
Enterprise to Revenue
1.26x
Updated Oct 27, 2026
Enterprise to EBITDA
8.60x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 17.14×.Updated Oct 27, 2026
Gross Margin
21.65%
Updated Oct 27, 2026
Profit Margin
-20.22%
Updated Oct 27, 2026
Operating Margin
6.81%
Updated Oct 27, 2026
Return on Assets (TTM)
3.32%
Updated Oct 27, 2026
Return on Equity (TTM)
-64.75%
Updated Oct 27, 2026
Revenue (TTM)
124.51MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
0.1920USDUpdated Oct 27, 2026
Quarterly Revenue Growth
130.00%
Updated Oct 27, 2026
Gross Profit (TTM)
24.83MUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
9.14MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
-25.18MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
130.02%
Updated Oct 27, 2026
Operating Cash Flow (TTM)
8.72MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
20.99MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
Updated Oct 27, 2026
Revenue
78.78MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
67.98MUSDFY2025 · Dec 31, 2025
Gross Profit
10.81MUSDFY2025 · Dec 31, 2025
Operating Income
2.22MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-34.13MUSDFY2025 · Dec 31, 2025
Income Tax Expense
3.26MUSDFY2025 · Dec 31, 2025
Net Income
-37.39MUSDFY2025 · Dec 31, 2025
EBIT
-29.44MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
9.14MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
9.69MUSDFY2025 · Dec 31, 2025
Other Operating Expenses
-1.20MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
1.57MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.68MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.0700USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.0700USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
524.17MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
524.17MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-37.39MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-11.56MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-15.12MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
41.56MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-37.39MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
5.21MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
3.26MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
644.00KUSDFY2025 · Dec 31, 2025
Other Non-cash Items
5.02MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-1.63MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
13.31MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-3.55MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-5.34MUSDFY2025 · Dec 31, 2025
Sale of Investments
2.83MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-6.06MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.51MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-2.66MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
35.90MUSDFY2025 · Dec 31, 2025
Shares Outstanding
753.60MSharesUpdated Oct 27, 2026
Float Shares
730.54MSharesUpdated Oct 27, 2026
% Held by Insiders
3.66%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
14.41%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
19.91MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
0.0260USDUpdated Oct 27, 2026
Total Debt (MRQ)
7.60MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
0.1091x
Updated Oct 27, 2026
Current Ratio (MRQ)
0.9270x
Updated Oct 27, 2026
Book Value per Share (MRQ)
0.0920USDUpdated Oct 27, 2026
Total Assets
104.63MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
65.82MUSDFY2025 · Dec 31, 2025
Total Liabilities
77.48MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
38.81MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
25.86MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
51.62MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
39.48MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
3.24MUSDFY2025 · Dec 31, 2025
Accounts Receivable
9.24MUSDFY2025 · Dec 31, 2025
Inventory
5.20MUSDFY2025 · Dec 31, 2025
Accounts Payable
18.02MUSDFY2025 · Dec 31, 2025
Short-term Debt
3.54MUSDFY2025 · Dec 31, 2025
Deferred Revenue
822.00KUSDFY2025 · Dec 31, 2025
Other Current Liabilities
1.84MUSDFY2025 · Dec 31, 2025
Long-term Debt
16.57MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
150.24MUSDFY2025 · Dec 31, 2025
Retained Earnings
-162.97MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
27.15MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
0.2140USDUpdated Oct 27, 2026
52-Week High
0.8420USDUpdated Oct 27, 2026
52-Week Change
-8.39%
vs all stocks
Updated Oct 27, 2026
Beta
2.45x
vs all stocks
Updated Oct 27, 2026
50-Day MA
0.3123USDUpdated Oct 27, 2026
200-Day MA
0.4067USDUpdated Oct 27, 2026
Avg 10-Day Volume
643.72KSharesUpdated Oct 27, 2026
Avg 30-Day Volume
744.99KSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
-0.0500USDUpdated Oct 27, 2026
Other Income / Expense
-33.36MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score -0.88: distress zoneCritical
Altman Z-Score: -0.88
High structural barrier to entryNotable
Barrier to Entry: 0.99
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $169.26M, lower than 95% of all stocks globallySignificant
Market cap (USD): 169,264,550Global P5: 273,689,256.68
Levered free cash flow is $20.99M, above the global median of $18.58MNotable